REVA Medical, Inc. (RVA) has 62 open-market insider trades by 18 insiders since 2010. The most active filer is Robert Bain Thomas, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Saints Capital Everest L.P. | 10% Owner | — | 3 | $14.4M | 2012-03-18 |
| Jesse I. Treu | 10% | — | 1 | $8.7M | 2012-03-23 |
| James C. Blair | 10% | — | 1 | $8.7M | 2012-03-23 |
| Kathleen K. Schoemaker | 10% | — | 1 | $8.7M | 2012-03-23 |
| Brian H. Dovey | Dir | — | 1 | $8.7M | 2018-06-29 |
| Partners V. Lp Domain | 10% | — | 1 | $8.5M | 2012-03-23 |
| Robert Bain Thomas | Dir | — | 13 | $557K | 2017-07-09 |
| Robert Bernard Stockman | Dir | — | 6 | $534K | 2017-07-09 |
| Robert K. Schultz | Pres | — | 2 | $400K | 2017-05-17 |
| Donald K. Brandom | SVPProduct Development | — | 13 | $306K | 2016-06-28 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Regina E. Groves | CEO | Buy | $5K | 2017-08-23 |
| Regina E. Groves | CEO | Buy | $4K | 2017-08-17 |
| Richard M. Kimes | Senior VP & Operations | Buy | $5K | 2017-08-17 |
| Robert K. Schultz | President | Sell | $366K | 2017-05-17 |
| Ross Breckenridge | Director | Buy | $13K | 2016-07-21 |
| Gordon E. Nye | Director | Buy | $25K | 2016-07-21 |
Companies that share insiders with RVA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Anne Keating | Director | Buy | $114K | 2016-07-15 |
| Robert Bain Thomas | Director | Buy | $224K | 2016-07-15 |
| Regina E. Groves | CEO | Buy | $20K | 2016-07-15 |
| Robert Bernard Stockman | Director | Buy | $150K | 2016-07-14 |
| Donald K. Brandom | SVP & Product Development | Sell | $7K | 2016-06-28 |
| Donald K. Brandom | SVP & Product Development | Sell | $26K | 2016-06-23 |
| Robert Bain Thomas | Director | Buy | $19K | 2016-06-17 |
| Donald K. Brandom | SVP & Product Development | Sell | $39K | 2016-06-17 |
| Robert Bain Thomas | Director | Buy | $21K | 2016-03-31 |